HOME >> MEDICINE >> NEWS
The Lancet Oncology and The Lancet Infectious Diseases

THE LANCET ONCOLOGY

THE TRUE COST OF A NUCLEAR DETERRENT

This months editorial covers the recent leaked report from the US Department of Health and Disease Control, showing the patterns of nuclear fallout across the US resulting from Cold War testing. The editorial discusses the impact of these data on cancer incidence and the worldwide effects of nuclear testing on the general population and military personnel. It concludes: 'It is easy to say that lessons should be learnt from the history of the nuclear deterrent, but unfortunately, with the escalation of the nuclear race in India and Pakistan, and the possibility of terrorist groups such as al-Qaeda acquiring materials to create crude nuclear devices, it is likely that the same mistakes will be repeated. We may never fully realise the true human cost of military advancement.'

REVIEWS

  • The evolution of tamoxifen therapy in breast cancer: selective oestrogen-receptor modulators and downregulators
  • Use of minimally invasive oesophagectomy for cancer of the oesophagus
  • Clinical management of dyspnoea
  • Mediastinal (thymic) large B-cell lymphoma: where do we stand?
  • Culprit and victim - DNA topoisomerase II
  • Cancer causation: the Darwinian downside of past success?

THE LANCET INFECTIOUS DISEASES

ENOUGH TIME WASTED IN SOUTH AFRICA

This months Leading Edge editorial discusses the South African Governments reluctance to provide the antiretroviral drug nevirapine to pregnant women with HIV. The drug has been shown to be effective in preventing mother-to-child HIV-1 transmission; however the South African Government have recently launched an appeal to a March 11 court hearing which instructed them to make the drug available in state facilities offering HIV-1 counselling and testing.

REVIEWS

  • Epidemiology of drug-resistant malaria
  • p values for pathogens: statistica
    '"/>


Contact: Richard Lane
richard.lane@lancet.com
44-20-7424-4949
Lancet
1-Apr-2002


Page: 1 2

Related medicine news :

1. The Lancet calls for the creation of a world institute for risk evaluation
2. The Lancet calls for creation of Intl Commission on Global Responses to Complex Emergencies
3. Majority of authors retract 1998 Lancet paper-Lancet editor points to implications
4. The Lancet Oncology (TLO)
5. The Lancet Infectious Diseases (TLID)
6. The Lancet Neurology November press release
7. Lancet readers to join WHO election debate
8. The Lancet Oncology press release
9. The Lancet Neurology October press release
10. The Lancet neurology press release
11. The Lancet Neurology press release

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/1/2017)... ... March 01, 2017 , ... Breast Surgeon, Dr. Dennis Holmes of ... stage breast cancer and where it fits in the treatment paradigm at Susan G. ... .” The event brings together leading cancer and wellness experts to share the latest ...
(Date:3/1/2017)... ... March 01, 2017 , ... ... increase colorectal cancer screening rates by supporting the 80% by 2018 initiative, led ... (CDC) and the National Colorectal Cancer Roundtable (an organization co-founded by ACS and ...
(Date:3/1/2017)... ... March 01, 2017 , ... “There is Comfort for the Soul”: a ... author in their all-too-brief time together, and the soul-healing comfort provided by God’s presence ... creation of published author, Jerie A. Tau, a dog-loving medical professional whose work takes ...
(Date:3/1/2017)... ... March 01, 2017 , ... “Letter of Love”: a tale of ... Teresa Hamilton, survivor of the Civil War in El Salvador, wife, mother, and co-founder ... of fifteen. I dedicated myself to serve in very poor communities, and I study ...
(Date:2/28/2017)... (PRWEB) , ... March 01, 2017 , ... ... the acquisition of SmarterMe, a personal assistant for sales powered by an intelligent ... enterprises to work smarter. , SmarterMe is built grounds up keeping individual users ...
Breaking Medicine News(10 mins):
(Date:3/1/2017)... Research and Markets has announced the addition of the "Global ... their offering. ... This analysis is one of the most accurate studies performed using ... data derived from varied research sources to present unique and reliable ... during the next five years, including a deep dive analysis of ...
(Date:3/1/2017)... 1, 2017 Utilizing a cloud-based, HIPAA-compliant ... three-phase program that offers providers the ability to ... if desired – move toward a self-distribution model ... episode of care. "The reality is ... to decrease," says Amin Rahme , president ...
(Date:3/1/2017)... PRUSSIA, Pa. , March 1, 2017  Global ... it has completed the largest ever Chronic Inflammatory Demyelinating ... A nd T reatment with H ... designed to demonstrate the efficacy, safety and tolerability of ... Hizentra ® (Immune Globulin Subcutaneous [Human]), compared with ...
Breaking Medicine Technology:
Cached News: